Navigation Links
ActivBiotics Outlines a Clinical Path Forward to Examine if Rifalazil Is Superior to Azithromycin in the Treatment of Chlamydia STD
Date:2/19/2008

WELLESLEY HILLS, Mass., Feb. 19 /PRNewswire/ -- Joseph F. Finn, Jr., CPA, the Assignee for the Benefit of Creditors of ActivBiotics, announced today the design of a clinical trial to investigate whether Chlamydia STD is treated adequately by currently approved antibiotics. Rifalazil, the most potent anti-chlamydial agent that has been administered to people, may provide a better treatment option for Chlamydia STD. The insidious aspect of Chlamydia STD is that infections which are inadequately treated can later result in serious consequences. A new, improved treatment would prevent the long-term detrimental effects of Chlamydia STD, which for women include mucopurulent cervicitis, pelvic inflammatory disease, ectopic pregnancy, and infertility. Chlamydia STD infections have also been associated with increased transmission of human immunodeficiency virus (HIV) in both men and women.

At the present time, the prevailing medical opinion is that Chlamydia STD is treated adequately by a single 1 gram oral dose of azithromycin. However, in a previous Phase II clinical trial (published in 2007 in the journal Sexually Transmitted Diseases), men experiencing symptoms of nongonococcal urethritis attributed to Chlamydia trachomatis infection had higher cure rates with rifalazil than with azithromycin five weeks after treatment. Although the sample size of the trial was small, these results certainly left room to consider the possibility of an improved therapy with rifalazil for treating all Chlamydia STDs.

The new trial would compare a group of women, all infected with Chlamydia STD, who would be administered a single oral dose of rifalazil with a similar group receiving a single dose of azithromycin. "We can examine if rifalazil is superior to azithromycin in eradicating Chlamydia STD in women by evaluating 55 subjects in each treatment group", said Walter Stamm from the University of Washington, a leading clinician in the area of Chlamydia STD. Indeed, suc
'/>"/>

SOURCE ActivBiotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
2. ActivBiotics to Present Results of Pivotal Study in the Treatment of Peripheral Arterial Disease at AHA Meeting
3. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
4. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
5. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
6. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
7. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
8. Raven Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas
9. Maine Natural Health Company Conducts Dental Clinical Trial
10. Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
11. AGI Dermatics Clinical Data Indicate Bicyclic Monoterpene Diols Suppress MMP1 and Stimulate Collagen Through TNF-a Signaling

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...etrics,Inc.,aprivately-helddeveloperandmarketeroft...ediagnosticsystemformeasuringanindividual,srespons...spirin),announcedtodaythatTimothyI.Still,President...ncialOfficerofAccumetrics,willbepresentingacorpora...ferencebeingheldinNewYorkCityonDecember1-2,2009atT...
(Date:11/24/2009)...partaSystems,Inc.,themakerofTrackWisesoftwareandth...ions,todayannouncedthatSSLInternationalplc,arapidl...yforgloballyrecognizedbrandssuchasDurexandScholl,h...System(EQMS).ThecompanyisnowleveragingtheTrackWise...tincludeCorrectiveandPreventiveAction(CAPA)managem...
(Date:11/24/2009)...swire/--America,spharmaceuticalresearchandbiotechn...eatorpreventHIV/AIDSandrelatedconditions,according...chandManufacturersofAmerica(PhRMA).December1markst...campaignthatoriginatedatthe1988WorldSummitofMinist...earegreatlyencouragedbythesecriticallyimportantmed...
Breaking Medicine Technology:Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 3New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Study Links Epilepsy to Brain Protein 57562 1Rare genetic disease successfully reversed using stem cell transplantation 9972 1Rare genetic disease successfully reversed using stem cell transplantation 9972 2Rare genetic disease successfully reversed using stem cell transplantation 9972 3Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 1Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 2
...to Explore the Efficacy of Novel Proteasome Inhibi...ry Multiple Myeloma, SOUTH SAN FRANCISCO, Calif. ...Research Consortium (MMRC) and Proteolix, Inc. tod...n a multi-center Phase 2,clinical trial to study P...or, carfilzomib (PR-171), in patients with relapse...
...nn., Aug. 15 Kevin McHale is,one of five board me..., a,non-profit organization incorporated in Saint ...sperson. HMH was created to gift cochlear implants... never be able to obtain one.,Dr. William House, t...its,on the Board of Directors., While the burden ...
Other Medicine Technology:The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4Kevin McHale Instrumental in Forming the 'Help Me Hear Foundation' 2
(Date:11/24/2009)...wswire/--Bionorica,aninternationalcompanypioneerin...heavailabilityofneweducationalresourcesforparentsw...ton"StayingNaturallyHealthyduringtheHolidays,"thef...nthecompany,swebsiteat www.bionoricausa.com . ,...totheNaturalMomstipsheets,withcontentcontributedby...
(Date:11/24/2009)...ire-FirstCall/--HealthSouthCorporation(NYSE: HLS )...errillLynch2009CreditConferenceinNewYorkonDec.2-3,...urerEdFaywillbespeakingonThursday,Dec.3,2009,at3:4...vailableat http://investor.healthsouth.com byclick..., HealthSouthisthenation,slargestproviderofinpati...
(Date:11/24/2009)...d off peripheral artery disease, researchers say ... Among people aged 75 and older, the herbal supple... stroke or death, a new study finds. , There is...t help prevent the leg-circulation problem known a...contains nutrients called flavonoids, which are al...
(Date:11/24/2009)...rt prospects, but cancer risk remains , ,... offers yet more proof that smoking is a major ris..., Researchers followed 12,152 American and Euro...nonsmokers for three years. During that time, curr...cancer, 2.26 times more likely to die of heart dis...
(Date:11/24/2009)...at plague older adults, study finds, , ,... leading cause of death among older Americans, and...es to those accidents. , "Pain contributes to f...ciated with mobility limitations that could predis...nic pain, no matter how we measured it, was associ...
Breaking Medicine News(10 mins):Health News:Bionorica Offers Expert Resources, Health Tips for 'Natural Moms' 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Smokers Double Their Risk for Heart Disease 2Health News:Chronic Pain Trips Up Seniors 2Health News:Chronic Pain Trips Up Seniors 3
...bal from Alirajpur in Jhabua district, beat his wi...g. In the same block,// another young man killed h...extract toddy from the palm trees owned by him. ...nd a 'bidi' (leaf rolled cigarette) to a friend. I...
... Germany said Thursday they have found compelling ...ldren, identifying three mutations// prevalent in ...ofessor Johannes Hebebrand of the University of Du... great majority -- around 70 percent -- had a comb...
..., United Nations special envoy for the fight again...Union initiative that would aim to curb the spread... the E.U. Parliament's development committee, Samp... are providing antiretrovirals to as many people a...
...tists have identified and cloned a rice gene that ...d help scientists develop// higher yielding variet... Little is known about the genetic mechanisms tha... week (8 April) in Nature Genetics, lead author Li...
...six other Northeastern states in the US are steppi...t to enact tougher standards of mercury emissions....ation has become a growing health concern. Mercury...ns drift across state borders, and the mercury lan...
...the annual report of UK’S National Institute of Me...est ever, there are also definite steps // being t... are reduced by 20 percent, within the next three ...treatment. Another problem area identified is of t...
Other Medicine News:Health News:Efforts Underway to Fight Alcoholism Among Tribals 2Health News:Efforts Underway to Fight Alcoholism Among Tribals 3Health News:Efforts Underway to Fight Alcoholism Among Tribals 4Health News:Scientists Find Rice Gene for Grain Size and Yield 2Health News:US States Get Ready to Fight Mercury Pollution 2
...ilter units with hydrophobic PTFE membranes,Millex... are ideal for the sterilizing filtration of gases...lizing or clarifying organic solutions. Ready-to-u... with different outlet connections; other filter u...
...ilter units with hydrophobic PTFE membranes,Millex... are ideal for the sterilizing filtration of gases...lizing or clarifying organic solutions. Ready-to-u... with different outlet connections; other filter u...
...to Bottled Water, The Simplicity personal water sy... that currently use bottled water. In addition to ...ttled water, your laboratory applications may be a...tainers and cause water quality to degrade over ti...
arium 611 Ultrapure Water Systems
Medicine Products: